FDA Issues Revised Draft Guidance on Reporting Drug Sample Information Under the ACA
To ensure comments are considered before work begins on the final version, comments on the draft should be submitted by October 9, 2014. The draft guidance is available here.
The author thanks Katelyn Ruiz for her assistance.
On 26 September 2016, a new EU-US collaboration between the European Medicines Agency (EMA) and the United States Food and Drug Administration (FDA) was announced. This new collaboration is ...06 October 2016
On 1 September 2016, the European Medicines Agency ("EMA") opened for public consultation a Draft revision to its Guideline on the assessment of clinical safety and efficacy in the...08 September 2016